M
DGX icon

Mirova’s Quest Diagnostics DGX Stock Holding History

Mirova’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-268
Closed -$37.7K – 133
2023
Q2 		$37.7K Sell
268
-453
-63% -$62.5K 0.01% 154
2023
Q1 		$102K Buy
+721
New +$103K 0.01% 152
2020
Q4 		– Sell
-1,811
Closed -$207K – 184
2020
Q3 		$207K Buy
+1,811
New +$214K 0.03% 65

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mirova's DGX Position: Q3 2023 in Review

Mirova sold out of Quest Diagnostics (DGX) in Q3 2023, closing a stake of 268 shares — an estimated $37.7K sold.

Mirova first reported a position in DGX in Q3 2020 and held it in 3 quarters. The position peaked at $207K in Q3 2020. 794 funds tracked by Wall St. Rank hold DGX as of Q3 2023.

  • Mirova reported no remaining Quest Diagnostics position as of Q3 2023 after selling out during the quarter.
  • Mirova sold 268 Quest Diagnostics shares in Q3 2023, an estimated $37.7K.
  • Mirova first reported a position in Quest Diagnostics in Q3 2020 and held it in 3 quarters.
  • Mirova's Quest Diagnostics position peaked at $207K in Q3 2020.
  • 794 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2023.

Based on Mirova's 13F filing for Q3 2023, filed 14 Nov 2023.